Stockreport

REFILE-Merck to further study Keytruda in prostate cancer after early success [Reuters]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF Merck to further study Keytruda in prostate cancer after early success (Reuters) - Merck & Co Inc said on Thursday it was launching three late-stage studies for its canc [Read more]